Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Ionis Pharmaceuticals receives orphan drug designation for HTTRx for the treatment of Huntington’s disease.

Ionis Pharmaceuticals Receives Orphan Drug Designation for HTTRx

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

BioPharm highlights the monoclonal antibodies that may gain United States regulatory approval in 2016.

mAbs to Watch in 2016

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Parenteral packaging of the future will include more automated lines, ready-to-fill packaging formats, and supply-chain transparency.

Parenteral Packaging: 2021

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Infrastructure and payer decisions will determine drug choices in emerging and developed regions.

Global Drug Directions

Amid corporate restructurings, regulatory initiatives, and aging R&D assets, will drug development accelerate or stall in 2016?

Bio/Pharma Navigates New Routes to Drug Development

FDA approved 45 novel new drugs in 2015, the highest number of approvals since 1996 and second-highest ever.

Expedited Approvals and Orphan Drugs Dominated 2015 Novel New Drugs

Regulatory, corporate restructuring, and manufacturing issues will challenge bio/pharma to meet the needs and expectations of patients around the world.

Bio/Pharma’s 2016 Agenda in Europe

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Liquid formulations in hard-shell capsules or softgels are becoming a popular option for HPAPIs because of advantages such as improved safety and lower risk of potential exposure and product cross contamination.

Liquid Encapsulation for HPAPIs

The DF30Plus, a new version of Aptar Pharma’s aerosol metering valve for pressurized metered dose inhalers (pMDIs), incorporates an elastomeric cyclic-olefin-copolymer (COC) neck gasket.

Metering Valve Incorporates COC Neck Gasket

Agnes Shanley is senior editor of Pharmaceutical Technology.

Synthetic biology promises to drive tomorrow’s therapies, while continuous processing is already being used in some new drugs.